Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Learn more about REXULTI for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

REXULTI® (brexpiprazole) Patient Information Website

Rexulti (Brexpiprazole): Side Effects, Use for Depression, and More

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Brexpiprazole Demonstrates Clinically Meaningful Improvements for Agitation Due to Alzheimer Disease

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

What is agitation that may happen with dementia due to Alzheimer's disease?

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

REXULTI® (brexpiprazole), Agitation associated with dementia due to Alzheimer's disease

SLU Researcher Finds Help for Alzheimer's-Associated Agitation with New FDA-Approved Treatment : SLU

Lundbeck: Alzheimer's agitation drug can make a real difference — MedWatch

Medicare coverage debates amplify as FDA approves Rexulti for Alzheimer's agitation

Otsuka and Lundbeck Issue Statement on REXULTI for Alzheimer's

Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer's dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference